Fig vs. Ro Tirzepatide: Which Is the Better Value?

When comparing online providers for compounded GLP-1 medications, Ro (formerly Roman) and Fig are two prominent options. Both offer asynchronous telehealth consultations and direct-to-door medication delivery.

However, when you look closely at the pricing structures—specifically for compounded tirzepatide—the difference in overall value is substantial. If you are trying to decide between Fig and Ro for your weight loss journey, here is a detailed breakdown of what you need to know.

The Subscription Trap: How Ro Prices Its Service

Ro operates on a model that separates the cost of "care" from the cost of the medication. This structure is common among heavily venture-backed telehealth companies, but it often results in higher out-of-pocket costs for the patient.

When you sign up for Ro's Body Program, you are required to pay a mandatory monthly membership fee.

Ro's Membership Fee: Ro charges $145 per month just for the membership. This fee covers the provider consultation, ongoing check-ins, and access to their app. This fee does not include the cost of the medication.
Ro's Medication Cost: If you are prescribed a compounded GLP-1, you must pay for the medication on top of the $145 membership fee.

This means that before a single vial of medication is even shipped, you are already spending $145 a month.

The Fig Difference: Zero Membership Fees

At Fig, we built our pricing model to be as transparent and accessible as possible. We fundamentally disagree with the practice of charging patients a subscription fee just for the right to purchase their prescribed medication.

Fig's Membership Fee: $0. We never charge monthly subscription fees, app access fees, or hidden coaching fees.
Fig's All-Inclusive Pricing: The price we quote is the total price. It includes the medical consultation, the prescription authorization, the compounded medication from a 503A pharmacy, and shipping.

Fig vs. Ro: Compounded Tirzepatide Cost Comparison

Let's look at the actual numbers if you are prescribed compounded tirzepatide.

(Note: Ro's exact pricing for compounded tirzepatide can fluctuate, but the membership fee remains constant. Fig's pricing is fixed and transparent.)

Fig's Pricing for Compounded Tirzepatide:

Monthly Plan: $279 total per month.
Quarterly Plan (3 months): $265 total per month.
6-Month Plan: $258 total per month.

Ro's Estimated Pricing:

Membership Fee: $145/month.
Estimated Medication Cost: While Ro heavily promotes brand-name access, patients seeking compounded options often find the total combined cost (membership + medication) exceeds $350 to $400+ per month.

Fig vs. Ro: Head-to-Head

Feature Fig Ro (Body Program) Mandatory Membership Fee $0 $145/month Pricing Structure All-inclusive (Meds + Care) Split (Membership + Meds) Total Cost for Tirzepatide From $258/month ~$350 - $400+/month (Estimated total) Total Cost for Semaglutide From $145/month ~$294+/month (Estimated total) Pharmacy Quality US-based, FDA-registered 503A US-based compounding pharmacies Telehealth Format Asynchronous online evaluation Asynchronous online evaluation

The Verdict: Why Pay a Membership Fee?

Both Fig and Ro provide access to high-quality compounded medications from US-based pharmacies. Both offer convenient online medical evaluations with licensed physicians.

The primary difference is that Ro charges you $145 a month for access, while Fig charges you $0.

If you are looking for the most cost-effective way to access compounded tirzepatide without sacrificing the quality of care or the medication, Fig is the clear winner. By eliminating subscription fees, Fig allows you to invest your money entirely in your treatment, making long-term weight management significantly more affordable.

Start your online evaluation with Fig today and see how much you can save.

Medical Disclaimer: Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness, or quality. Fig does not guarantee weight loss results. Individual outcomes vary. Treatment is only prescribed when a licensed provider determines it is clinically appropriate.